Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

City Therapeutics, Inc.

NASDAQ: CTY · Life Sciences · 4 alerts · CIK 2143850

Share price
$16.98Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All City Therapeutics, Inc. filings on SEC EDGAR ↗

7:07 AM ET 8-K
Business Update

City Therapeutics Business Update

City Therapeutics announced the first participant has been dosed in its Phase 1 clinical trial of CITY-RBP4 for the treatment of Stargardt disease. The trial is a first-in-human study evaluating the safety, tolerability, and pharmacodynamics of the RNAi therapeutic candidate, with initial data expected in mid-2027.

5:39 PM ET Form 4
Insider Buying

City Therapeutics Insider ARCH Venture Partners XII LLC Buys $3.06M of Stock

ARCH Venture Partners XII LLC bought 170,000 shares of City Therapeutics, Inc. at $18.00 a share, worth $3.06M in total on Oct 19, 2026. Shares held after the trade: 13,692,507 (+1.3%).

Value
$3.06M
Shares
170,000
Price
$18.00
Holding change
+1.3%
Trade date
Oct 19, 2026
5:38 PM ET Form 4
Insider Buying

City Therapeutics Insider Robert Nelsen Buys $3.06M of Stock

Robert Nelsen bought 170,000 shares of City Therapeutics, Inc. at $18.00 a share, worth $3.06M in total on Oct 19, 2026. Shares held after the trade: 13,692,507 (+1.3%).

Value
$3.06M
Shares
170,000
Price
$18.00
Holding change
+1.3%
Trade date
Oct 19, 2026
5:12 PM ET 8-K
Other 8-K Filing

City Therapeutics Other 8-K Filing

City Therapeutics filed its amended and restated certificate of incorporation and bylaws in connection with the completion of its initial public offering. The amendments authorize 500 million shares of common stock and 10 million shares of undesignated preferred stock while eliminating stockholder action by written consent. These administrative changes are standard corporate governance updates triggered by the company's transition to a public entity.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.